Archived Medical News Stories

RSSArchived Drug Trial News Stories - September 2008

Date Title Comments Rating
2008-09-30 Plethora Solutions completes European trial of PSD502 for premature ejaculation 0 1
2008-09-30 Arthritis treatments glucosamine and chondroitin shown to be no better than placebo 0 None
2008-09-29 Warfarin linked to increased bleeding in brain 0 None
2008-09-28 Anticancer drug triggers nanoparticle formation, improves stability in vivo 0 None
2008-09-25 Array BioPharma presents positive data on its glucokinase activators in type 2 diabetes 0 None
2008-09-25 Concert Pharmaceuticals initiates CTP-347 phase I clinical trial 0 None
2008-09-25 Data Safety Monitoring Board supports continuation of trial of Iluvien for diabetic macular edema 0 None
2008-09-24 Popular COPD treatment increases risk for cardiac events, cardiac death 1 5
2008-09-21 Arana updates inflammatory pipeline milestones 0 None
2008-09-17 S*BIO initiates trials of oral JAK2 inhibitor for hematological malignancies 0 None
2008-09-17 Combo of flu shot and COLD-FX cuts cold and flu by a third 0 None
2008-09-16 New drug might make tumor cells more sensitive to therapy 0 None
2008-09-16 New results help predict treatment response in colorectal cancer 0 None
2008-09-16 Benefits of combined treatments against cancer 0 None
2008-09-16 Study questions use of newer antipsychotic drugs in children 0 None
2008-09-16 New drug substantially extends survival in pancreatic cancer 0 None
2008-09-16 Older antipsychotic drugs as effective, offer fewer side effects in children than newer drugs, study finds 0 None
2008-09-15 Trabectedin shows promise for ovarian cancer 0 None
2008-09-15 Promising new treatment option for women with recurrent ovarian cancer 0 None
2008-09-15 Newer atypical antipsychotic medications no better than older drug in treating child and adolescent schizophrenia 0 None
2008-09-15 Investigational drug shows promise in ovarian cancer 0 4
2008-09-15 DNA vaccine developed at the Karmanos Cancer Institute fights HER2-positive cancers 0 None
2008-09-15 Adding Taxotere to chemotherapy regimen improves survival in early breast cancer 0 None
2008-09-15 Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment 0 None
2008-09-11 Phase I trial for new tuberculosis vaccine 0 None
2008-09-11 Naltrexone-derived pyridomorphinan shows promise for treatment of alcoholism 0 5
2008-09-10 New drug promises once-a-day treatment for asthma and hay fever 0 None
2008-09-10 New drug hope for cystic fibrosis patients 0 None
2008-09-09 Receptor activation protects retina from diabetes destruction 0 None
2008-09-09 New drug hope for cystic fibrosis patients 0 None
2008-09-08 New treatment for diabetics identified 0 None
2008-09-08 Once a week treatment for type 2 diabetes in the pipeline 0 None
2008-09-07 Trial demonstrates safety and efficacy of neurally acting anti-migraine agent for treatment of acute migraine 0 None
2008-09-07 Trastuzumab-DM1 - a 'smart bomb' for breast cancer treatment 0 None
2008-09-04 Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma 0 None
2008-09-04 Second phase 3 trial of Bronchitol in cystic fibrosis sufferers begins 0 None
2008-09-04 Clinical trial advances cystic fibrosis therapy 0 None
2008-09-03 Diffusion Pharmaceuticals initiates phase I/II clinical trial in patients with peripheral arterial disease 0 None
2008-09-03 Further analysis from ATHENA study showed Multaq (Dronedarone) reduced risk of stroke in patients with atrial fibrillation 0 None
2008-09-03 FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation 0 None
2008-09-03 Ondansetron helps reduce vomiting, hospital admissions in children with gastroenteritis 0 None
2008-09-03 Anadis Ltd's clinical trial against mucositis approved in Israel 0 None
2008-09-02 Fibrex medical reports positive phase II results for peptide for the treatment of reperfusion injury 0 None
2008-09-02 Pre-hospital treatment on the way to percutaneous coronary intervention 0 None
2008-09-02 Safety of antithrombotic treatment in acute coronary syndromes 0 None
2008-09-02 The effects of A2 inhibitor Darapladib on human coronary athlerosclerotic plaque 0 None
2008-09-02 Factor Xa inhibitor Apixaban and antiplatelet therapy after acute coronary syndrome 0 None
2008-09-02 Fibrin-derived peptide FX06 reduces cardiac reperfusion injury 0 None
2008-09-02 Overcoming poor response to standard oral antiplatelet agents 0 None
2008-09-02 Results from the Simvastatin and Ezetimibe in aortic stenosis study 0 None
2008-09-02 Myocardial regeneration by intracoronary infusion in AMI (REGENT) randomized trial 0 None
2008-09-02 MorphoSys announces publication of first MOR103 data 0 None
2008-09-01 Bryostatin extends stroke treatment time to 24 hours, repairs brain tissue 0 None
2008-09-01 New diagnostic tools and biomarkers 0 None
2008-09-01 Fluvastatin XL use is associated with improved cardiac outcome after major vascular surgery 0 None


55 posts
5 raters